Ahmet Hacimuftuoglu
Overview
Explore the profile of Ahmet Hacimuftuoglu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
165
Citations
1057
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Das U, Hacimuftuoglu A, Akpinar E, Gul M, Abd El-Aty A
Lipids Health Dis
. 2025 Feb;
24(1):52.
PMID: 39962508
Renin plays a significant role in the regulation of blood pressure and fluid volume by modulating the renin‒angiotensin‒aldosterone (RAAS) system. Renin suppression reduces serum aldosterone levels and lowers blood pressure...
2.
Yang H, Zhang C, Kim W, Shi M, Kiliclioglu M, Bayram C, et al.
Elife
. 2025 Feb;
13.
PMID: 39932177
Excessive consumption of sucrose, in the form of sugar-sweetened beverages, has been implicated in the pathogenesis of metabolic dysfunction-associated fatty liver disease (MAFLD) and other related metabolic syndromes. The c-Jun...
3.
Turkez H, Alper F, Bayram C, Baba C, Yildiz E, Saracoglu M, et al.
Med Oncol
. 2025 Jan;
42(2):47.
PMID: 39821858
Limited advancements in managing malignant brain tumors have resulted in poor prognoses for glioblastoma (GBM) patients. Standard treatment involves surgery, radiotherapy, and chemotherapy, which lack specificity and damage healthy brain...
4.
Yulug B, Altay O, Li X, Hanoglu L, Cankaya S, Velioglu H, et al.
Brain Commun
. 2025 Jan;
7(1):fcae478.
PMID: 39816194
Parkinson's disease is primarily marked by mitochondrial dysfunction and metabolic abnormalities. We recently reported that the combined metabolic activators improved the immunohistochemical parameters and behavioural functions in Parkinson's disease and...
5.
Aydin I, Ferah Okkay I, Okkay U, Ozkaraca M, Yesilyurt F, Yilmaz A, et al.
Vet Med Sci
. 2025 Jan;
11(1):e70048.
PMID: 39745481
The present study aimed to unveil the gastroprotective potential of Vaccinium macrocarpon (VM) extract and its mechanism of action against indomethacin (INDO)-induced gastric ulcers in rats. To achieve this goal,...
6.
Yeni Y, Nadaroglu H, Ertugrul M, Hacimuftuoglu A, Alayli A
Toxicol Rep
. 2024 Dec;
13:101818.
PMID: 39649381
Nanoparticles are attracting attention for their potential therapeutic applications, particularly in cancer therapy, underscoring their importance in medicine. Cadmium sulfide nanoparticles, known for their robust catalytic and optical properties, are...
7.
Yeni Y, Genc S, Nadaroglu H, Hacimuftuoglu A
Naunyn Schmiedebergs Arch Pharmacol
. 2024 Nov;
PMID: 39527310
One aspect of glutamate (Glut) toxicity may be the opening of the blood-brain barrier to albumin (Al), which in itself can cause nerve cell death. Quercetin (Q) is a polyphenolic...
8.
Yeni Y, Cicek B, Yildirim S, Bolat I, Hacimuftuoglu A
Toxicol Rep
. 2024 Nov;
13:101762.
PMID: 39484633
Therapeutic approaches based on isolated compounds derived from natural products are more common in preventing diseases involving inflammation and oxidative stress at present. S-allyl cysteine (SAC) is a promising garlic-derived...
9.
Celik H, Akcay G, Savas A, Yesilyurt F, Demirdogen F, Ates D, et al.
Turk Neurosurg
. 2024 Oct;
34(6):1117-1121.
PMID: 39474969
Aim: To determine the effects of different concentrations of Trolox on the cytotoxic, oxidant, antioxidant, and cytokine levels in the SH-SY5Y cell line. Material And Methods: SH-SY5Y cells were grown...
10.
Varmazyari A, Taghizadehghalehjoughi A, Sevim C, Baris O, Eser G, Yildirim S, et al.
Toxicol Rep
. 2024 Sep;
13:101707.
PMID: 39224456
[This corrects the article DOI: 10.1016/j.toxrep.2020.04.011.].